The problem in this is that the first 3 drugs are for the same disease i.e R/R Multiple Myeloma. Which affects a small population .
Until the company can demonstrate that BEAT/TREAT can be used in other diseases the upside potential will be limited . There are 2 drugs for hematological malignancy & solid tumor namely ISB 2004 & 2301 in discovery stage, let see how they fare.
| Subscribe To Our Free Newsletter |
